دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The first Debate and a focus on trials
Filippo Crea
doi : 10.1093/eurheartj/ehab536
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 2959–2962
Cardio Egypt 2021: one of the first physical meetings in the era of Covid-19
Magdy Abdelhamid, Mohamed Osama, Khaled Shokry
doi : 10.1093/eurheartj/ehab206
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 2963–2965
Heart, mind, and soul: spirituality in cardiovascular medicine
Kavitha M Chinnaiyan, Rishab Revankar, Michael D Shapiro, Ankur Kalra
doi : 10.1093/eurheartj/ehab080
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 2965–2968
European Heart Journal Team Heart Failure
doi : 10.1093/eurheartj/ehab284
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Page 2968
Reflections on Hypertrophic Cardiomyopathy
Eugene Braunwald, M.D
doi : 10.1093/eurheartj/ehab337
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 2969–2970
No blossom for fractional flow reserve in FLOWER-MI
Antonio Maria Leone, Giovanna Liuzzo
doi : 10.1093/eurheartj/ehab425
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 2971–2972
Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy: Introduction
Filippo Crea
doi : 10.1093/eurheartj/ehab277
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 2973–2985
Interpreting myocardial infarction analyses in ISCHEMIA: separating facts from fallacy
Raffaele De Caterina, David L Brown
doi : 10.1093/eurheartj/ehab405
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 2986–2989
The importance of achieving sex- and gender-based equity in clinical trials: a call to action
Jeske van Diemen, Petra Verdonk, Alaide Chieffo, Evelyn Regar, Fina Mauri, Vijay Kunadian, Garima Sharma, Roxana Mehran, Yolande Appelman
doi : 10.1093/eurheartj/ehab457
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 2990–2994
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
Jackie Bosch, Eva M Lonn, Hyejung Jung, Jun Zhu, Lisheng Liu, Patricio Lopez-Jaramillo, Prem Pais, Denis Xavier, Rafael Diaz, Gilles Dagenais, Antonio Dans, Alvaro Avezum, Leopoldo S Piegas, Alexander Parkhomenko, Kati Keltai, Matyas Keltai, Karen Sliwa, Claus Held, Ronald J G Peters, Basil S Lewis, Petr Jansky, Khalid Yusoff, Kamlesh Khunti, William D Toff, Christopher M Reid, John Varigos, Philip Joseph, Lawrence A Leiter, Salim Yusuf the Heart Outcomes Prevention Evaluation (HOPE)-3 Investigators
doi : 10.1093/eurheartj/ehab225
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 2995–3007
Rosuvastatin (10 mg per day) compared with placebo reduced major adverse cardiovascular (CV) events by 24% in 12 705 participants at intermediate CV risk after 5.6 years. There was no benefit of blood pressure (BP) lowering treatment in the overall group, but a reduction in events in the third of participants with elevated systolic BP. After cessation of all the trial medications, we examined whether the benefits observed during the active treatment phase were sustained, enhanced, or attenuated.
The legacy of HOPE-3
Eric Boersma, Isabella Kardys
doi : 10.1093/eurheartj/ehab208
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 3008–3010
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study
Ewa A Jankowska, Bridget-Anne Kirwan, Mikhail Kosiborod, Javed Butler, Stefan D Anker, Theresa McDonagh, Maria Dorobantu, Jaros?aw Drozdz, Gerasimos Filippatos, Andre Keren, Irakli Khintibidze, Hans Kragten, Felipe A Martinez, Marco Metra, Davor Milicic, José C Nicolau, Marcus Ohlsson, Alexander Parkhomenko, Domingo A Pascual-Figal, Frank Ruschitzka, David Sim, Hadi Skouri, Peter van der Meer, Basil S Lewis, Josep Comin-Colet, Stephan von Haehling, Alain Cohen-Solal, Nicolas Danchin, Wolfram Doehner, Henry J Dargie, Michael Motro, Tim Friede, Vincent Fabien, Fabio Dorigotti, Stuart Pocock, Piotr Ponikowski the AFFIRM-AHF Investigators
doi : 10.1093/eurheartj/ehab234
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 3011–3020
Patients with heart failure (HF) and iron deficiency experience poor health-related quality of life (HRQoL). We evaluated the impact of intravenous (IV) ferric carboxymaltose (FCM) vs. placebo on HRQoL for the AFFIRM-AHF population.
Iron supplementation in acute heart failure: energize your life
Tibor Kempf
doi : 10.1093/eurheartj/ehab365
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 3021–3022
Underlying mechanisms involved in the icosapent ethyl reduction of cardiovascular events still cannot be attributed to an anti-atherosclerotic effect
Gaston A Rodriguez-Granillo, Hector M Garcia-Garcia
doi : 10.1093/eurheartj/ehab230
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 3023–3024
The EVAPORATE trial provides important mechanistic data on plaque characteristics that have relevance to the REDUCE-IT results and clinical use of icosapent ethyl
Matthew Budoff, Suvasini Lakshmanan, Deepak L Bhatt
doi : 10.1093/eurheartj/ehab233
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Pages 3025–3026
Diffuse coronary encasement by thymic cancer
Ju-Yi Chen
doi : 10.1093/eurheartj/ehaa1046
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Page 3024
A gigantic coronary pseudoaneurysm in a 60-year-old man
Hongbo Yang, Shufu Chang, Juying Qian, Junbo Ge
doi : 10.1093/eurheartj/ehab014
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Page 3027
Takotsubo cardiomyopathy following temporal lobe encephalitis—a case of ‘Harry Potter’ syndrome
Santhiya Kumarakulasingam, Dhanya Salimkumar, Juno Sunny, Angela Gallagher, Mohammed Y Khanji
doi : 10.1093/eurheartj/ehab016
European Heart Journal, Volume 42, Issue 31, 14 August 2021, Page 3028
